Suppr超能文献

与CFTR相关的配体阻止突变型ΔF508 CFTR通道在内质网中的转运,这与囊性纤维化的发生有关。

The CFTR-Associated Ligand Arrests the Trafficking of the Mutant ΔF508 CFTR Channel in the ER Contributing to Cystic Fibrosis.

作者信息

Bergbower Emily, Boinot Clement, Sabirzhanova Inna, Guggino William, Cebotaru Liudmila

机构信息

The Graduate Training Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Cell Physiol Biochem. 2018;45(2):639-655. doi: 10.1159/000487120. Epub 2018 Jan 29.

Abstract

BACKGROUND/AIMS: The CFTR-Associated Ligand (CAL), a PDZ domain containing protein with two coiled-coil domains, reduces cell surface WT CFTR through degradation in the lysosome by a well-characterized mechanism. However, CAL's regulatory effect on ΔF508 CFTR has remained almost entirely uninvestigated.

METHODS

In this study, we describe a previously unknown pathway for CAL by which it regulates the membrane expression of ΔF508 CFTR through arrest of ΔF508 CFTR trafficking in the endoplasmic reticulum (ER) using a combination of cell biology, biochemistry and electrophysiology.

RESULTS

We demonstrate that CAL is an ER localized protein that binds to ΔF508 CFTR and is degraded in the 26S proteasome. When CAL is inhibited, ΔF508 CFTR retention in the ER decreases and cell surface expression of mature functional ΔF508 CFTR is observed alongside of enhanced expression of plasma membrane scaffolding protein NHERF1. Chaperone proteins regulate this novel process, and ΔF508 CFTR binding to HSP40, HSP90, HSP70, VCP, and Aha1 changes to improve ΔF508 CFTR cell surface trafficking.

CONCLUSION

Our results reveal a pathway in which CAL regulates the cell surface availability and intracellular retention of ΔF508 CFTR.

摘要

背景/目的:CFTR相关配体(CAL)是一种含有两个卷曲螺旋结构域的PDZ结构域蛋白,通过一种已明确的机制在溶酶体中降解,从而减少细胞表面的野生型CFTR。然而,CAL对ΔF508 CFTR的调节作用几乎完全未被研究。

方法

在本研究中,我们描述了一条此前未知的CAL作用途径,通过结合细胞生物学、生物化学和电生理学方法,CAL通过在内质网(ER)中阻止ΔF508 CFTR的转运来调节其膜表达。

结果

我们证明CAL是一种定位于内质网的蛋白,它与ΔF508 CFTR结合并在26S蛋白酶体中降解。当CAL受到抑制时,ΔF508 CFTR在内质网中的滞留减少,同时观察到成熟功能性ΔF508 CFTR的细胞表面表达以及质膜支架蛋白NHERF1的表达增强。伴侣蛋白调节这一新过程,并且ΔF508 CFTR与HSP40、HSP90、HSP70、VCP及Aha1的结合发生变化,以改善ΔF508 CFTR的细胞表面转运。

结论

我们的结果揭示了一条CAL调节ΔF508 CFTR细胞表面可用性和细胞内滞留的途径。

相似文献

2
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
Biochemistry. 2008 Sep 23;47(38):10084-98. doi: 10.1021/bi8003928. Epub 2008 Aug 29.
4
Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.
Am J Physiol Cell Physiol. 2000 Feb;278(2):C259-67. doi: 10.1152/ajpcell.2000.278.2.C259.
8
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.
Cell. 2006 Nov 17;127(4):803-15. doi: 10.1016/j.cell.2006.09.043.

引用本文的文献

1
Identification of novel natural compounds against CFTR p.Gly628Arg pathogenic variant.
AMB Express. 2024 Sep 9;14(1):99. doi: 10.1186/s13568-024-01762-9.
3
CTNNAL1 deficiency suppresses CFTR expression in HDM-induced asthma mouse model through ROCK1-CAL signaling pathway.
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1618-1629. doi: 10.3724/abbs.2023152.
4
Ubiquitin-like processing of TUG proteins as a mechanism to regulate glucose uptake and energy metabolism in fat and muscle.
Front Endocrinol (Lausanne). 2022 Sep 29;13:1019405. doi: 10.3389/fendo.2022.1019405. eCollection 2022.
5
Drug efficacy and toxicity prediction: an innovative application of transcriptomic data.
Cell Biol Toxicol. 2020 Dec;36(6):591-602. doi: 10.1007/s10565-020-09552-2. Epub 2020 Aug 11.
6
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.
Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019.
7
Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.
Int J Mol Sci. 2020 Jan 10;21(2):452. doi: 10.3390/ijms21020452.
8
Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.
J Phys Chem B. 2019 Dec 12;123(49):10441-10455. doi: 10.1021/acs.jpcb.9b07278. Epub 2019 Nov 27.
9
The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.
J Biol Chem. 2019 Nov 29;294(48):18269-18284. doi: 10.1074/jbc.RA119.010192. Epub 2019 Oct 23.
10
Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis.
Front Pharmacol. 2018 Oct 1;9:1112. doi: 10.3389/fphar.2018.01112. eCollection 2018.

本文引用的文献

1
Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
Clin Pharmacol Ther. 2017 Jan;101(1):130-141. doi: 10.1002/cpt.548. Epub 2016 Nov 23.
3
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.
Nat Genet. 2013 Oct;45(10):1160-7. doi: 10.1038/ng.2745. Epub 2013 Aug 25.
4
Insulin-like growth factor 1 (IGF-1) enhances the protein expression of CFTR.
PLoS One. 2013;8(3):e59992. doi: 10.1371/journal.pone.0059992. Epub 2013 Mar 28.
5
Rescue of ΔF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway.
Cell. 2011 Sep 2;146(5):746-60. doi: 10.1016/j.cell.2011.07.021.
6
Evaluation of the disease liability of CFTR variants.
Methods Mol Biol. 2011;742:355-72. doi: 10.1007/978-1-61779-120-8_21.
7
Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator.
Mol Biol Cell. 2010 Apr 1;21(7):1178-87. doi: 10.1091/mbc.e09-03-0229. Epub 2010 Feb 3.
9
VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.
Am J Respir Cell Mol Biol. 2007 Jun;36(6):706-14. doi: 10.1165/rcmb.2006-0365OC. Epub 2007 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验